Breach of listing rules 10.11 and 14.7 | 12-Dec-20 |
Letter to shareholders | 29-Dec-20 |
Letter to option holders expiry of listed options | 16-Dec-20 |
New issue announcement appendix 2A | 14-Dec-20 |
Change of director’s interest notice | 14-Dec-20 |
Underwriter to advance $500,000 | 08-Dec-20 |
Trading suspension | 08-Dec-20 |
New issue announcement | 08-Dec-20 |
Exclusive option to acquire strategic stake in beach toes | 08-Dec-20 |
ASX reinstatement | 08-Dec-20 |
Appendix-2A Options | 08-Dec-20 |
Appendix-2A Cleansing | 08-Dec-20 |
Trading halt | 05-Dec-20 |
Change of Director’s Interest Notice | 19-Nov-20 |
Change of Principal Place of Business and Registered Office | 17-Nov-20 |
Response to ASX Price and Volume Query | 16-Nov-20 |
TGA Submission for Hospital Grade Invisi Shield Disinfectant | 11-Nov-20 |
Initial Director’s Interest Notice | 4-Nov-20 |
Final Director’s Interest Notice | 4-Nov-20 |
Appendix 4G and Corporate Governance Statement | 3-Nov-20 |
Annual Report to shareholders | 3-Nov-20 |
Appendix 4C – quarterly | 2-Nov-20 |
New Director Appointed | 29-Oct-20 |
Response to ASX Query Letter | 23-Oct-20 |
Update on Termination of Agreement | 19-Oct-20 |
Response to ASX Query Letter | 15-Oct-20 |
Company Update | 15-Oct-20 |
Company Secretary Appointment/Resignation | 9-Oct-20 |
extension to lodge audited accounts | 9-Sep-20 |
Preliminary Final Report | 31-Aug-20 |
new securities issue | 26-Aug-20 |
Appendix 2A | 26-Aug-20 |
Appendix 2A | 26-Aug-20 |
SKN enters into $2.4 million distribution agreement | 7-Aug-20 |
Appendix 4C – quarterly | 31-Jul-20 |
Response to ASX Query Letter | 3-Jul-20 |
Appendix 2A | 26-Jun-20 |
Proposed issue of Securities – SKN | 26-Jun-20 |
Appendix 2A | 26-Jun-20 |
Response to AFR article | 18-Jun-20 |
Disclosure Document | 12-Jun-20 |
new securities announcement | 12-Jun-20 |
Trading Halt | 8-May-20 |
Pause in Trading | 8-May-20 |
Appendix 4C – quarterly | 30-Apr-20 |
SKN Invisi-Shield Natural Sanitiser Update | 30-Apr-20 |
SKN announces $10.5m Options Underwriting Agreement | 16-Apr-20 |
SKN enters collaboration with HCT on natural sanitiser | 3-Apr-20 |
Trading Halt | 2-Apr-20 |
Response to ASX Appendix 3Y Query Letter | 30-Mar-20 |
Amended change of Director’s interest notice | 30-Mar-20 |
Change of Director’s Interest Notice | 26-Mar-20 |
Appendix 2A | 26-Mar-20 |
New Securities Issues | 23-Mar-20 |
Reinstatement to Official Quotation | 20-Mar-20 |
SKN announcement on Invisi Shield hand sanitiser | 20-Mar-20 |
Response to ASX Query Letter | 19-Mar-20 |
Appendix 2A | 17-Mar-20 |
Appendix 2A | 17-Mar-20 |
Non-Renounceable Issue | 17-Mar-20 |
Response to ASX Price Query | 16-Mar-20 |
SKN launches new skin medical range | 12-Mar-20 |
Response to query regarding accounts | 11-Mar-20 |
Suspension from Official Quotation | 10-Mar-20 |
Trading Halt | 6-Mar-20 |
Half Yearly Report and Accounts | 2-Mar-20 |
Non-Renounceable Issue | 24-Feb-20 |
Non-Renounceable Issue | 24-Feb-20 |
Non-Renounceable Issue | 14-Feb-20 |
Change of Director’s Interest Notice | 7-Feb-20 |
Change of Director’s Interest Notice | 7-Feb-20 |
Appendix 2A | 7-Feb-20 |
Proposed issue of Securities – SKN | 7-Feb-20 |
Proposed issue of Securities – SKN | 6-Feb-20 |
Disclosure Document | 5-Feb-20 |
Non-Renounceable Issue | 5-Feb-20 |
Appendix 4C – quarterly | 31-Jan-20 |
Non-Renounceable Issue | 21-Jan-20 |
Trading Halt | 17-Jan-20 |